Marine Biomedical Secures FDA Clearance for PearlBone Graft with Orthocell Stake
Marine Biomedical has secured FDA clearance for its PearlBone graft, triggering potential commercialization efforts supported by a 12% equity stake held by…

Marine Biomedical has received US Food and Drug Administration 510(k) clearance for its PearlBone bone graft substitute. This regulatory approval permits the product to be marketed within the United States for orthopedic, trauma, and reconstructive surgical applications.
Orthocell holds a 12% equity interest in Marine Biomedical following a $1.05 million investment. The agreement grants Orthocell a right of first refusal regarding global distribution rights for PearlBone and future product iterations.
Marine Biomedical
Orthocell intends to leverage its existing US commercial infrastructure and surgeon networks to facilitate the market entry of the biomaterial. The product utilizes nacre sourced from pearl shells, with manufacturing operations currently centralized in Western Australia.
This development represents a strategic expansion for Orthocell, aiming to integrate bone regeneration technology into its existing portfolio of nerve and tendon repair products. Marine Biomedical is currently finalizing manufacturing readiness and commercial partnership strategies ahead of the formal US launch.
More stories
- The Week in Games: GTA 6 turns attention into cash
- US data centres emit 25.7m tonnes of CO2, Harvard says
- German founders need 3,942 hours to open small business
- Leaked Deutsche Bank files test Sewing's reform narrative
- UAE employers plan 2.8% pay rises for 2027
- Bessent urges Nvidia to seek outside CEO as scrutiny grows
- Bioventus cuts 2026 revenue view to $590m-$595m
- Kimco buys Louisville retail centers for $295m
- Nasdaq falls 1.66% after Alphabet shares slide 13.2%
- ACCO Brands lifts 2026 EPS outlook to $0.98-$1.02
Latest news
- David Parr House to honor Victorian art-workman with blue plaque
- Iran's attacks hit 25 tankers near Strait of Hormuz
- FCC approves prison cellphone jamming despite 2.5-mile warning
- Russia strikes Ukraine as Odesa faces electricity strain
- Bahrain reports two injuries after Iranian aerial attacks
- Congress tests Black Democrats' growing policy influence
- Baltic responders fight Sparta II fire after drone strike
- Dietitians advise small swaps for plant-based eating

